PM1021
/ BioNTech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 08, 2023
A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Biotheus Inc. | Initiation date: Dec 2022 ➔ Oct 2023
Combination therapy • Metastases • Monotherapy • Trial initiation date • Oncology • Solid Tumor
September 13, 2022
A Study of PM1021 (Anti-TIGIT) With or Without PM8001 (Anti-PD-L1/TGF-β) in Patients With Advanced Solid Tumours
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Biotheus Inc.
Combination therapy • Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1